NCT06640010 Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events
| NCT ID | NCT06640010 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Hematopoietic and Lymphatic System Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-02-12 |
| Primary Completion | 2027-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2025-02-12 with a primary completion date of 2027-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is being done to find out if patient blood samples can be used to perform individualized modeling of cancer therapy-related side effects.
Eligibility Criteria
Inclusion Criteria: * Any patient \>= 18 years of age * Previously treated, planned or currently receiving any potentially toxic cancer therapy including but not limited to chemotherapy, targeted and immunotherapies Exclusion Criteria: * Inability on the part of the patient to understand the informed consent or be compliant with the protocol
Contact & Investigator
Nadine Norton, PhD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT06640010 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hematopoietic and Lymphatic System Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06640010 currently recruiting?
Yes, NCT06640010 is actively recruiting participants. Contact the research team at mayocliniccancerstudies@mayo.edu for enrollment information.
Where is the NCT06640010 trial being conducted?
This trial is being conducted at Jacksonville, United States.
Who is sponsoring the NCT06640010 clinical trial?
NCT06640010 is sponsored by Mayo Clinic. The principal investigator is Nadine Norton, PhD at Mayo Clinic. The trial plans to enroll 30 participants.